TheMediTary.Com

Diarylquinolines are antimycobacterial drugs that interfere with mycobacterial energy production by binding and inhibiting subunit c of ATP synthase in the mycobacterium. The mycobactericidal activity is due to it being unable to generate energy. Diarylquinolines are used as part of combination therapy in pulmonary multi-drug resistant tuberculosis (MDR-TB) and usually administered as directly observed therapy (DOT).